Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Stock
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
262.81 CNY | +3.06% | +0.89% | -9.56% |
Capitalization | 318B 43.72B 41.37B 38.35B 34.3B 61.81B 3,703B 68.43B 477B 176B 1,521B 164B 161B 6,555B | P/E ratio 2024 * |
24.3x | P/E ratio 2025 * | 20.7x |
---|---|---|---|---|---|
Enterprise value | 297B 40.78B 38.59B 35.78B 32B 57.66B 3,454B 63.83B 445B 165B 1,419B 153B 150B 6,115B | EV / Sales 2024 * |
7.66x | EV / Sales 2025 * | 6.38x |
Free-Float |
42.59% | Yield 2024 * |
2.53% | Yield 2025 * | 2.93% |
1 day | +3.06% | ||
1 week | +0.89% | ||
Current month | +0.89% | ||
1 month | -4.29% | ||
3 months | +8.55% | ||
6 months | -13.74% | ||
Current year | -9.56% |
Director | Title | Age | Since |
---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 52 | 2020-11-16 |
Yun Zhao
DFI | Director of Finance/CFO | 41 | 2019-11-14 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 61 | 2021-04-26 |
Manager | Title | Age | Since |
---|---|---|---|
Hang Xu
CHM | Chairman | 62 | 1999-01-24 |
Xi Ting Li
CHM | Chairman | 73 | 2017-01-04 |
Ming He Cheng
BRD | Director/Board Member | 63 | 2017-01-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.79% | 1 M€ | -20.08% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+3.06% | +0.89% | -6.76% | -24.34% | 43.72B | ||
+1.63% | -0.05% | +7.20% | -14.93% | 202B | ||
+0.50% | +1.55% | +77.40% | +70.00% | 196B | ||
+0.99% | -3.99% | +4.24% | -25.02% | 166B | ||
-0.51% | -0.65% | +64.30% | +121.30% | 133B | ||
-0.54% | +0.23% | -2.21% | -19.32% | 60.84B | ||
-1.24% | +0.25% | +2.94% | -36.11% | 42.19B | ||
+1.97% | +1.89% | +9.05% | -7.19% | 40.09B | ||
-0.40% | -2.38% | +19.38% | - | 37.12B | ||
+0.84% | -3.06% | +47.20% | -7.26% | 35.43B | ||
Average | +0.42% | -0.79% | +22.28% | +6.35% | 95.69B | |
Weighted average by Cap. | +0.61% | -0.72% | +29.60% | +19.94% |
2024 * | 2025 * | |
---|---|---|
Net sales | 38.7B 5.32B 5.04B 4.67B 4.18B 7.53B 451B 8.33B 58.11B 21.48B 185B 20B 19.55B 798B | 45.46B 6.25B 5.92B 5.49B 4.91B 8.84B 530B 9.79B 68.25B 25.23B 218B 23.49B 22.97B 938B |
Net income | 13.11B 1.8B 1.71B 1.58B 1.41B 2.55B 153B 2.82B 19.68B 7.28B 62.74B 6.77B 6.62B 270B | 15.44B 2.12B 2.01B 1.86B 1.67B 3B 180B 3.32B 23.19B 8.57B 73.91B 7.98B 7.8B 318B |
Net Debt | -21.34B -2.93B -2.78B -2.57B -2.3B -4.15B -249B -4.59B -32.04B -11.84B -102B -11.03B -10.78B -440B | -27.65B -3.8B -3.6B -3.34B -2.98B -5.38B -322B -5.95B -41.52B -15.35B -132B -14.29B -13.97B -570B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-06 | 262.81 ¥ | +3.06% | 6,987,174 |
24-12-05 | 255.00 ¥ | -1.76% | 5,107,458 |
24-12-04 | 259.56 ¥ | -0.44% | 3,629,556 |
24-12-03 | 260.71 ¥ | -0.95% | 5,205,387 |
24-12-02 | 263.21 ¥ | +1.04% | 6,149,144 |
End-of-day quote Shenzhen S.E., December 05, 2024
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock